<didl:DIDL xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:didl="urn:mpeg:mpeg21:2002:02-DIDL-NS" xmlns:dii="urn:mpeg:mpeg21:2002:01-DII-NS" xmlns:dip="urn:mpeg:mpeg21:2002:01-DIP-NS" xmlns:dcterms="http://purl.org/dc/terms/" xsi:schemaLocation="urn:mpeg:mpeg21:2002:02-DIDL-NS http://standards.iso.org/ittf/PubliclyAvailableStandards/MPEG-21_schema_files/did/didl.xsd urn:mpeg:mpeg21:2002:01-DII-NS http://standards.iso.org/ittf/PubliclyAvailableStandards/MPEG-21_schema_files/dii/dii.xsd urn:mpeg:mpeg21:2005:01-DIP-NS http://standards.iso.org/ittf/PubliclyAvailableStandards/MPEG-21_schema_files/dip/dip.xsd" DIDLDocumentId="https://arxiv.universalpublishings.com/id/eprint/92423">
  <didl:Item>
    <didl:Descriptor>
      <didl:Statement mimeType="application/xml">
        <dii:Identifier>https://arxiv.universalpublishings.com/id/eprint/92423</dii:Identifier>
      </didl:Statement>
    </didl:Descriptor>
    <didl:Descriptor>
      <didl:Statement mimeType="application/xml">
        <dcterms:modified>2026-06-06T15:14:38Z</dcterms:modified>
      </didl:Statement>
    </didl:Descriptor>
    <didl:Component>
      <didl:Resource mimeType="application/xml" ref="https://arxiv.universalpublishings.com/cgi/export/eprint/92423/DIDL/arxiv-eprint-92423.xml"/>
    </didl:Component>
    <didl:Item>
      <didl:Descriptor>
        <didl:Statement mimeType="application/xml">
          <dip:ObjectType>info:eu-repo/semantics/descriptiveMetadata</dip:ObjectType>
        </didl:Statement>
      </didl:Descriptor>
      <didl:Component>
        <didl:Resource mimeType="application/xml">
          <oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
        <dc:relation>https://arxiv.universalpublishings.com/id/eprint/92423/</dc:relation>
        <dc:title>FEATURES OF THE TREATMENT OF AUTOIMMUNE THYROID DISEASES IN ADOLESCENT BOYS</dc:title>
        <dc:creator>Shoruhbek, Arabboyev</dc:creator>
        <dc:description>This study examined clinical features, immunological markers, and hormonal profiles of autoimmune thyroiditis (AIT) in 72 adolescent males aged 12–17 years. Anti-TPO titers (248.6±32.4 IU/mL) and TSH levels (5.8±1.2 mIU/L) were significantly elevated compared to controls (p&amp;lt;0.001). Subclinical hypothyroidism was detected in 43.1% of cases. The findings support the need for broader AIT screening in adolescent males.
&amp;nbsp;</dc:description>
        <dc:publisher>Center for Tech and Media Research</dc:publisher>
        <dc:date>2026-06-06</dc:date>
        <dc:type>Maqola</dc:type>
        <dc:type>NonPeerReviewed</dc:type>
        <dc:identifier>  Shoruhbek, Arabboyev  (2026) FEATURES OF THE TREATMENT OF AUTOIMMUNE THYROID DISEASES IN ADOLESCENT BOYS.  Multidisciplinary Journal of Science and Technology; Vol. 6 No. 6 (2026): Multidisciplinary Journal of Science and Technology; 63-65.       </dc:identifier>
        <dc:relation>https://mjstjournal.com/index.php/mjst/article/view/7631</dc:relation>
        <dc:relation>oai:ojs.pkp.sfu.ca:article/7631</dc:relation>
        <dc:identifier>oai:ojs.pkp.sfu.ca:article/7631</dc:identifier></oai_dc:dc>
        </didl:Resource>
      </didl:Component>
    </didl:Item>
    <didl:Item>
      <didl:Descriptor>
        <didl:Statement mimeType="application/xml">
          <dip:ObjectType>info:eu-repo/semantics/humanStartPage</dip:ObjectType>
        </didl:Statement>
      </didl:Descriptor>
      <didl:Component>
        <didl:Resource ref="https://arxiv.universalpublishings.com/id/eprint/92423/" mimeType="application/html"/>
      </didl:Component>
    </didl:Item>
  </didl:Item>
</didl:DIDL>